Cours Titan Pharmaceuticals, Inc. OTC Bulletin Board
Actions
TTNP
US8883141017
Produits pharmaceutiques
CA 2022 | 557 k 505 k | CA 2023 | 184 k 167 k | Capitalisation | 6,21 M 5,63 M |
---|---|---|---|---|---|
Résultat net 2022 | -10 M -9,06 M | Résultat net 2023 | -5 M -4,53 M | VE / CA 2022 | 15,6 x |
Trésorerie nette 2022 | 2,75 M 2,49 M | Trésorerie nette 2023 | 6,2 M 5,61 M | VE / CA 2023 | 0,11 x |
PER 2022 |
-1,03
x | PER 2023 |
-1,11
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 54,53% |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Avraham Ben-Tzvi
BRD | Director/Board Member | 53 | 15/08/22 |
Gim Shen Seow
CEO | Chief Executive Officer | 42 | 12/10/23 |
Brynner Chiam
BRD | Director/Board Member | - | 12/10/23 |
Varia. 1 janv. | Capi. | |
---|---|---|
+30,38% | 684 Md | |
+26,51% | 568 Md | |
-4,36% | 361 Md | |
+19,30% | 329 Md | |
+3,73% | 284 Md | |
+16,70% | 240 Md | |
+8,78% | 208 Md | |
-7,93% | 200 Md | |
+7,68% | 166 Md |